Impact of clinical trials by biopharmacetical companies on their market share price

Published: 19 April 2022| Version 1 | DOI: 10.17632/4rtz4dp24f.1
Contributor:
Oleg Saraev

Description

This data provides information about how clinical trials of biopharmaceutical companies effect on their market share price. This issue was done by Event Study of 50 larges biopharmacetical companies for 2015-2020 period. Also, this files contains regeression results of how chemtype of approved drugs affects on AR and how R&D capacity affecting on AR of the selected companies.

Files

Institutions

Moskovskij gosudarstvennyj universitet imeni M V Lomonosova

Categories

Applied Sciences

Licence